United Kingdom
Lipid biomarkers for newborn screening of treatable metabolic diseases: Discovery, assay Development, and implementation
A LIPID MAPS Webinar hosted by Val O'Donnell with guest speaker Professor Michael Gelb
Date: 23 May 2023 @ 17:00 - 18:00
Timezone: Amsterdam
About Prof. Michael Gelb
Michael H. Gelb is Professor of Chemistry and Barbara L. Weinstein Endowed Chair in Chemistry, Adjunct Professor of Biochemistry at the University of Washington. Major developments in the Gelb lab include discovery of protein prenylation, development of ICAT proteomic reagents, identification of phospholipases involved in lipid mediator generation, development of anti-parasite drugs, and development of mass spectrometry for newborn screening. Awards include: Repligen Award in Chemistry of Biological Processes (Amer. Chem. Soc.), Univ.of Washington Faculty Lecture Award, Gustavus John Esselen Award (Harvard Univ.), AAAS Fellow, NIH Merit Award, Medicines for Malaria Project of the Year Award, Pfizer Award in Enzyme Chemistry, ICI Pharmaceuticals Award for Excellence in Chemistry. The Gelb lab has published more than 500 papers and 100 patents in biological chemistry. The Gelb laboratory has developed mass spectrometry for worldwide newborn screening of lysosomal storage diseases (the latest expansion of newborn screening panels).
Contact: https://www.lipidmaps.org/about/contact
Keywords: lipid, lipidomics, lipid maps , lipidmaps
Organizer: LIPID MAPS
Cost basis: Free to all
Sponsors: Merck
Scientific topics: Lipidomics
Activity log
